PL2710013T3 - Nowe związki jako inhibitory acylotransferazy diacyloglicerolowej - Google Patents
Nowe związki jako inhibitory acylotransferazy diacyloglicerolowejInfo
- Publication number
- PL2710013T3 PL2710013T3 PL12789931T PL12789931T PL2710013T3 PL 2710013 T3 PL2710013 T3 PL 2710013T3 PL 12789931 T PL12789931 T PL 12789931T PL 12789931 T PL12789931 T PL 12789931T PL 2710013 T3 PL2710013 T3 PL 2710013T3
- Authority
- PL
- Poland
- Prior art keywords
- novel compounds
- diacylglycerol acyltransferase
- acyltransferase inhibitors
- inhibitors
- diacylglycerol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1452DE2011 | 2011-05-20 | ||
US201161503728P | 2011-07-01 | 2011-07-01 | |
EP12789931.8A EP2710013B1 (en) | 2011-05-20 | 2012-05-18 | Novel compounds as diacylglycerol acyltransferase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2710013T3 true PL2710013T3 (pl) | 2017-08-31 |
Family
ID=47217645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12789931T PL2710013T3 (pl) | 2011-05-20 | 2012-05-18 | Nowe związki jako inhibitory acylotransferazy diacyloglicerolowej |
Country Status (34)
Country | Link |
---|---|
US (4) | US8859536B2 (pl) |
EP (1) | EP2710013B1 (pl) |
JP (1) | JP5844456B2 (pl) |
KR (1) | KR101919080B1 (pl) |
CN (1) | CN103703009B (pl) |
AU (1) | AU2012259044B2 (pl) |
BR (1) | BR112013029935B1 (pl) |
CA (1) | CA2836669C (pl) |
CO (1) | CO6811855A2 (pl) |
CR (1) | CR20130602A (pl) |
CY (1) | CY1118188T1 (pl) |
DK (1) | DK2710013T3 (pl) |
DO (1) | DOP2013000272A (pl) |
EA (1) | EA023030B1 (pl) |
ES (1) | ES2588748T3 (pl) |
HK (1) | HK1194738A1 (pl) |
HR (1) | HRP20161089T1 (pl) |
HU (1) | HUE028870T2 (pl) |
IL (1) | IL229488A (pl) |
LT (1) | LT2710013T (pl) |
MA (1) | MA35185B1 (pl) |
ME (1) | ME02479B (pl) |
MX (1) | MX346494B (pl) |
MY (1) | MY184553A (pl) |
PE (1) | PE20141204A1 (pl) |
PL (1) | PL2710013T3 (pl) |
PT (1) | PT2710013T (pl) |
RS (1) | RS55006B1 (pl) |
SG (1) | SG195044A1 (pl) |
SI (1) | SI2710013T1 (pl) |
SM (1) | SMT201600328B (pl) |
UA (1) | UA111360C2 (pl) |
WO (1) | WO2012162129A1 (pl) |
ZA (1) | ZA201308664B (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2710013T3 (en) | 2011-05-20 | 2016-09-26 | Glaxosmithkline Intellectual Property (No 2) Ltd | New compounds such as diacylglycerol-acyltransferase inhibitors |
WO2014081996A1 (en) * | 2012-11-23 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds as diacylglycerol acyltransferase inhibitors |
US9796729B2 (en) | 2012-11-23 | 2017-10-24 | Glaxosmithkline Llc | Compounds as diacylglycerol acyltransferase inhibitors |
US20150322082A1 (en) | 2012-11-23 | 2015-11-12 | Glaxosmithkline Llc | Novel compounds as diacylglycerol acyltransferase inhibitors |
CN103524431B (zh) * | 2013-09-24 | 2016-01-13 | 西安交通大学 | 3-苄基-4-喹唑啉酮类化合物及其合成方法和应用 |
WO2015049668A1 (en) | 2013-10-03 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel compound as a diacylglycerol acyltransferase inhibitor |
WO2015049667A1 (en) | 2013-10-03 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel compound as a diacylglycerol acyltransferase inhibitor |
CN103880757B (zh) * | 2014-04-15 | 2016-02-24 | 上海毕得医药科技有限公司 | 一种5-羟基嘧啶-2-羧酸的合成方法 |
US20180125816A1 (en) | 2015-05-11 | 2018-05-10 | Cadila Healthcare Limited | Saroglitazar magnesium for the treatment of chylomicronemia syndrome |
US10385017B2 (en) | 2015-10-14 | 2019-08-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
CN105732461A (zh) * | 2016-02-03 | 2016-07-06 | 常州工程职业技术学院 | 5-甲氧基-6-卤代吲哚的制备方法 |
CN106083707B (zh) * | 2016-06-01 | 2018-10-26 | 温州大学 | 一种非对称杂芳基硫醚的合成方法 |
CN107619932B (zh) * | 2016-07-15 | 2020-08-07 | 中国科学院上海有机化学研究所 | 一种萃取组合物、萃取体系及其应用 |
CN107619928B (zh) * | 2016-07-15 | 2020-08-07 | 中国科学院上海有机化学研究所 | 一种萃取组合物、萃取体系及其应用 |
RU2706655C1 (ru) * | 2019-01-28 | 2019-11-19 | Акционерное общество "Гознак" (АО "Гознак") | Полимерсодержащее композиционное защищенное изделие |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090036425A1 (en) * | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
NZ593537A (en) * | 2008-12-19 | 2013-07-26 | Genentech Inc | Isoquinoline derivatives and methods of use |
TW201038580A (en) * | 2009-02-02 | 2010-11-01 | Pfizer | 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives |
EP2408766A1 (en) * | 2009-03-18 | 2012-01-25 | Schering Corporation | Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
CN102292329B (zh) * | 2009-04-24 | 2014-09-03 | 霍夫曼-拉罗奇有限公司 | 布鲁顿酪氨酸激酶的抑制剂 |
DK2710013T3 (en) | 2011-05-20 | 2016-09-26 | Glaxosmithkline Intellectual Property (No 2) Ltd | New compounds such as diacylglycerol-acyltransferase inhibitors |
US9796729B2 (en) | 2012-11-23 | 2017-10-24 | Glaxosmithkline Llc | Compounds as diacylglycerol acyltransferase inhibitors |
-
2012
- 2012-05-18 DK DK12789931.8T patent/DK2710013T3/en active
- 2012-05-18 MY MYPI2013702195A patent/MY184553A/en unknown
- 2012-05-18 HU HUE12789931A patent/HUE028870T2/en unknown
- 2012-05-18 MX MX2013013566A patent/MX346494B/es active IP Right Grant
- 2012-05-18 EP EP12789931.8A patent/EP2710013B1/en active Active
- 2012-05-18 ME MEP-2016-159A patent/ME02479B/me unknown
- 2012-05-18 JP JP2014511575A patent/JP5844456B2/ja not_active Expired - Fee Related
- 2012-05-18 KR KR1020137033509A patent/KR101919080B1/ko active IP Right Grant
- 2012-05-18 EA EA201391737A patent/EA023030B1/ru unknown
- 2012-05-18 RS RS20160648A patent/RS55006B1/sr unknown
- 2012-05-18 ES ES12789931.8T patent/ES2588748T3/es active Active
- 2012-05-18 BR BR112013029935-5A patent/BR112013029935B1/pt not_active IP Right Cessation
- 2012-05-18 SG SG2013085501A patent/SG195044A1/en unknown
- 2012-05-18 SI SI201230689A patent/SI2710013T1/sl unknown
- 2012-05-18 CA CA2836669A patent/CA2836669C/en not_active Expired - Fee Related
- 2012-05-18 WO PCT/US2012/038523 patent/WO2012162129A1/en active Application Filing
- 2012-05-18 CN CN201280035792.5A patent/CN103703009B/zh not_active Expired - Fee Related
- 2012-05-18 UA UAA201314878A patent/UA111360C2/uk unknown
- 2012-05-18 US US14/118,976 patent/US8859536B2/en not_active Expired - Fee Related
- 2012-05-18 LT LTEP12789931.8T patent/LT2710013T/lt unknown
- 2012-05-18 PE PE2013002531A patent/PE20141204A1/es active IP Right Grant
- 2012-05-18 PL PL12789931T patent/PL2710013T3/pl unknown
- 2012-05-18 AU AU2012259044A patent/AU2012259044B2/en not_active Ceased
- 2012-05-18 PT PT127899318T patent/PT2710013T/pt unknown
-
2013
- 2013-11-18 IL IL229488A patent/IL229488A/en active IP Right Grant
- 2013-11-19 ZA ZA2013/08664A patent/ZA201308664B/en unknown
- 2013-11-20 CR CR20130602A patent/CR20130602A/es unknown
- 2013-11-20 CO CO13273126A patent/CO6811855A2/es active IP Right Grant
- 2013-11-20 DO DO2013000272A patent/DOP2013000272A/es unknown
- 2013-12-13 MA MA36566A patent/MA35185B1/fr unknown
-
2014
- 2014-08-08 HK HK14108145.1A patent/HK1194738A1/zh not_active IP Right Cessation
- 2014-09-05 US US14/478,309 patent/US9040517B2/en not_active Expired - Fee Related
-
2015
- 2015-04-24 US US14/695,206 patent/US9273069B2/en not_active Expired - Fee Related
-
2016
- 2016-01-15 US US14/996,318 patent/US9540400B2/en active Active
- 2016-08-25 HR HRP20161089TT patent/HRP20161089T1/hr unknown
- 2016-09-19 CY CY20161100926T patent/CY1118188T1/el unknown
- 2016-09-20 SM SM201600328T patent/SMT201600328B/it unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1194738A1 (zh) | 作為二酰基甘油酰基轉移酶抑制劑的新化合物 | |
HK1206735A1 (en) | Diacylglycerol acyltransferase inhibitors | |
HRP20180139T1 (hr) | Supstituirani piridopirazini kao novi syk-inhibitori | |
ZA201309561B (en) | Novel inhibitor compounds of phosphodiestarase type 10a | |
EP2706852A4 (en) | BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS | |
EP2770987A4 (en) | NEW CONNECTIONS AS ERK HEMMER | |
EP2717694A4 (en) | NEW COMPOUNDS | |
IL229487A0 (en) | New compounds as diacylglycerol acyltransferase inhibitors | |
HRP20190099T1 (hr) | Novi spojevi kao inhibitori diacilglicerin aciltransferaze | |
EP2916839A4 (en) | NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE HEMMER | |
BR112013029805A2 (pt) | novos compostos como inibidores de diacilglicerol aciltransferase | |
GB201104399D0 (en) | Novel inhibitors |